Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

This summary covers recent developments in health from the death tied to a cyberattack on Synnovis services in the UK, the Eli Lilly and Novo Nordisk rivalry in the weight-loss drug market in India, ...

India’s oil imports from US surged over 270% in first four months of year; one of the five ADMs recall the events following ...

Group Captain Shubhanshu Shukla has become the first Indian to reach the International Space Station (ISS) on the Axiom-4 ...

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...

The success of Zohran Mamdani in New York City's Democratic primary for mayor is euphoric for Hari Kondabolu, a stand-up ...

Two new injectable drugs offer hope to the obese, especially diabetics, and could set off a pharma race to cash in on the ...

For 1Q25, (Inst.) underperformed the Fund’s benchmark, the Russell 3000 Healthcare Index. Click here to read the full commentary.

India is seeing an unhealthy rise in cases of the chronic disease affecting kids, but awareness and resources remain low.

SNS Insider Projects Explosive Growth in the U.S. Microservices in Healthcare Market—Valued at USD 114.75 Million in 2023—Fueled by HIPAA-Compliant Cloud Platforms, Modular EHR Integration, and ...